Atreca, Inc.
BCELDelisted Mar 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001532346
Atreca, Inc. was delisted on Mar 20, 2024; its insiders filed their last Form 4 on Apr 17, 2024; 43 institutions reported holding it in 13F filings for Q4 2023, worth $1.24M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Atreca, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- −1 vs. Q2 2021
- Shares held
- 23.4M
- −3.99M (−14.6%) vs. Q2 2021
- Total value
- $145.8M
- −$87.6M (−37.5%) vs. Q2 2021
- New holders
- 14
- 33 more added
- Sold out
- 15
- 33 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 7 | $79.4K |
| Q4 2023 | 43 | $1.24M |
| Q3 2023 | 45 | $3.24M |
| Q2 2023 | 53 | $13.4M |
| Q1 2023 | 54 | $16.3M |
| Q4 2022 | 59 | $11.6M |
| Q3 2022 | 65 | $25.1M |
| Q2 2022 | 80 | $29.8M |
| Q1 2022 | 93 | $60.9M |
| Q4 2021 | 100 | $65.7M |
| Q3 2021 | 107 | $145.8M |
| Q2 2021 | 108 | $233.5M |
| Q1 2021 | 105 | $428.1M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Atreca, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Logos Global Management LP | 1,175,000 | $7.32M | 0.53% | +1,175,000 | New |
| Vanguard Group Inc | 1,363,992 | $8.50M | 0.00% | +11,884+0.9% | Added |
| Bill & Melinda Gates Foundation | 1,396,644 | $8.70M | 2.55% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,934,255 | $12.1M | 0.00% | −516,198−21.1% | Reduced |
| Boxer Capital, LLC | 2,202,333 | $13.7M | 0.48% | 00.0% | Unchanged |
| BlackRock Inc. | 2,960,456 | $18.4M | 0.00% | +84,906+3.0% | Added |
| Baker Bros. Advisors LP | 3,532,760 | $22.0M | 0.10% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −2,426,685−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −373,706−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −198,570−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −113,455−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −100,628−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −42,945−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −40,339−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −37,163−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −34,465−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,009−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −21,500−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −12,161−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,192−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |